Hansa Biopharma Announces New Board Appointments
Lund, Sweden, September 24, 2026. Hansa Biopharma AB (publ), “Hansa” (Nasdaq Stockholm: HNSA), announced today the election of Shannon Campbell and Gregory Perry to Hansa’s Board of Directors, effective September 22, 2026 until the end of the next Annual General Meeting.
